Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786 [Periódico revisado por pares]

United States

Texto completo disponível